Abstract:Osteoporosis (OP) is distinguished by a reduction in bone mass and degradation of bone micro-structure, frequently resulting in fractures. As the geriatric demographic expands, the incidence of affected individuals progressively rises, thereby exerting a significant impact on the quality of life experienced by individuals. The flavonoid compound hesperidin has been subject to investigation regarding its effects on skeletal health, albeit the precise mechanisms through which it operates remain ambiguous. This study utilized network pharmacology to predict the core targets and signaling pathways implicated in the anti-OP properties of hesperidin. Molecular docking and molecular dynamics simulations were employed to confirm the stability of the interaction between hesperidin and the core targets. The effects of hesperidin on osteoblastic cells MC3T3-E1 were assessed using MTT, ELISA, alkaline phosphatase assay, and RT-qPCR techniques. Furthermore, in vivo experiments were conducted to determine the potential protective effects of hesperidin on zebrafish bone formation and oxidative stress response. The results demonstrate that network pharmacology has identified 10 key target points, significantly enriched in the estrogen signaling pathway. Hesperidin exhibits notable promotion of MC3T3-E1 cell proliferation and significantly enhances ALP activity. ELISA measurements indicate an elevation in NO levels and a reduction in IL-6 and TNF-α. Moreover, RT-qPCR analysis consistently reveals that hesperidin significantly modulates the mRNA levels of ESR1, SRC, AKT1, and NOS3 in MC3T3-E1 cells. Hesperidin promotes osteogenesis and reduces oxidative stress in zebrafish. Additionally, we validate the stable and tight binding of hesperidin with ESR1, SRC, AKT1, and NOS3 through molecular dynamics simulations. In conclusion, our comprehensive analysis provides evidence that hesperidin may exert its effects on alleviating OP through the activation of the estrogen signaling pathway via ESR1. This activation leads to the upregulation of SRC, AKT, and eNOS, resulting in an increase in NO levels. Furthermore, hesperidin promotes osteoblast-mediated bone formation and inhibits pro-inflammatory cytokines, thereby alleviating oxidative stress associated with OP.

Hepcidin and osteoporosis

Hepcidin-induced reduction in iron content and PGC-1β expression negatively regulates osteoclast differentiation to play a protective role in postmenopausal osteoporosis

Advance in Hepcidin

Physiological and Pathophysiological Mechanisms of Hepcidin Regulation: Clinical Implications for Iron Disorders

Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

The changes of ferroportin 1, iron ion, and mineralization and ossific genes in hFOB 1.19 cells after the intervention with hepcidin

Iron accumulation induced by hepcidin1 knockout accelerates the progression of aging osteoporosis

Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis

HO-1 in Bone Biology: Potential Therapeutic Strategies for Osteoporosis

Hesperidin Anti-Osteoporosis by Regulating Estrogen Signaling Pathways

Relationship Between Iron Overload Caused by Abnormal Hepcidin Expression and Liver Disease: A Review

Changes in escape rhythms several years after radiofrequency ablation of the atrioventricular junction combined with pacemaker implantation

Ferroptosis: A New Regulatory Mechanism in Osteoporosis

In-depth review: is hepcidin a marker for the heart and the kidney?

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

Role of hepcidin in murine brain iron metabolism

Effect of binding of palmitoly-CoA with adenine-nucleotide translocase on mitochondrial energization

Invasion by nonnative brook trout in Panther Creek, Idaho: Roles of local habitat quality, biotic resistance, and connectivity to source habitats

Iron metabolism and iron disorders revisited in the hepcidin era

Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration

Rifampin-resistant Mycobacterium kansasii.